West Capital Lease Obligations from 2010 to 2025
| WST Stock | USD 222.20 3.86 1.71% |
Capital Lease Obligations | First Reported 2019-03-31 | Previous Quarter 102.2 M | Current Value 99.7 M | Quarterly Volatility 15.9 M |
Check West Pharmaceutical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among West Pharmaceutical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 163.2 M, Total Revenue of 3 B or Gross Profit of 1 B, as well as many indicators such as Price To Sales Ratio of 8.68, Dividend Yield of 0.0023 or PTB Ratio of 9.36. West financial statements analysis is a perfect complement when working with West Pharmaceutical Valuation or Volatility modules.
West | Capital Lease Obligations |
Latest West Pharmaceutical's Capital Lease Obligations Growth Pattern
Below is the plot of the Capital Lease Obligations of West Pharmaceutical Services over the last few years. West Pharmaceutical capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to West Pharmaceutical asset purchases. For example, West Pharmaceutical can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as West Pharmaceutical control over an asset for a big portion of its life. It is the total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee. West Pharmaceutical's Capital Lease Obligations historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in West Pharmaceutical's overall financial position and show how it may be relating to other accounts over time.
| Capital Lease Obligations | 10 Years Trend |
|
Capital Lease Obligations |
| Timeline |
West Capital Lease Obligations Regression Statistics
| Arithmetic Mean | 79,379,896 | |
| Geometric Mean | 78,412,946 | |
| Coefficient Of Variation | 17.13 | |
| Mean Deviation | 11,219,844 | |
| Median | 72,000,000 | |
| Standard Deviation | 13,597,959 | |
| Sample Variance | 184.9T | |
| Range | 38.5M | |
| R-Value | 0.71 | |
| Mean Square Error | 97.3T | |
| R-Squared | 0.51 | |
| Significance | 0 | |
| Slope | 2,037,610 | |
| Total Sum of Squares | 2773.6T |
West Capital Lease Obligations History
About West Pharmaceutical Financial Statements
West Pharmaceutical shareholders use historical fundamental indicators, such as Capital Lease Obligations, to determine how well the company is positioned to perform in the future. Although West Pharmaceutical investors may analyze each financial statement separately, they are all interrelated. The changes in West Pharmaceutical's assets and liabilities, for example, are also reflected in the revenues and expenses on on West Pharmaceutical's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Capital Lease Obligations | 99.7 M | 96.4 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for West Stock Analysis
When running West Pharmaceutical's price analysis, check to measure West Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy West Pharmaceutical is operating at the current time. Most of West Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of West Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move West Pharmaceutical's price. Additionally, you may evaluate how the addition of West Pharmaceutical to your portfolios can decrease your overall portfolio volatility.